Silverlake Wealth Management LLC Makes New Investment in The Clorox Company (NYSE:CLX)

Silverlake Wealth Management LLC acquired a new position in shares of The Clorox Company (NYSE:CLX) in the 1st quarter, according to its most recent Form 13F filing with the SEC. The firm acquired 2,296 shares of the company’s stock, valued at approximately $352,000.

Several other institutional investors and hedge funds have also recently bought and sold shares of CLX. Vanguard Group Inc. lifted its stake in Clorox by 0.3% in the third quarter. Vanguard Group Inc. now owns 15,341,234 shares of the company’s stock valued at $2,010,622,000 after buying an additional 44,344 shares during the last quarter. Morgan Stanley lifted its position in Clorox by 1.8% in the third quarter. Morgan Stanley now owns 1,738,928 shares of the company’s stock worth $227,904,000 after purchasing an additional 30,902 shares during the period. Point72 Asset Management L.P. bought a new position in Clorox during the 4th quarter valued at $144,844,000. Norges Bank acquired a new position in Clorox during the fourth quarter worth about $128,382,000. Finally, Parsifal Capital Management LP bought a new stake in shares of Clorox in the 4th quarter worth approximately $128,245,000. Institutional investors and hedge funds own 78.53% of the company’s stock.

Clorox Stock Performance

Shares of NYSE CLX opened at $133.54 on Wednesday. The Clorox Company has a one year low of $114.68 and a one year high of $169.14. The company has a current ratio of 0.90, a quick ratio of 0.53 and a debt-to-equity ratio of 9.73. The business has a fifty day simple moving average of $136.74 and a 200 day simple moving average of $143.73. The firm has a market capitalization of $16.58 billion, a price-to-earnings ratio of 69.19, a PEG ratio of 2.19 and a beta of 0.39.

Clorox (NYSE:CLX) last posted its earnings results on Tuesday, April 30th. The company reported $1.71 earnings per share for the quarter, beating analysts’ consensus estimates of $1.33 by $0.38. The business had revenue of $1.81 billion for the quarter, compared to analysts’ expectations of $1.87 billion. Clorox had a net margin of 3.33% and a return on equity of 302.49%. The firm’s revenue for the quarter was down 5.3% on a year-over-year basis. During the same quarter in the previous year, the firm posted $1.51 earnings per share. Sell-side analysts expect that The Clorox Company will post 5.91 EPS for the current year.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on CLX shares. DA Davidson restated a “neutral” rating and set a $162.00 target price on shares of Clorox in a report on Wednesday, April 17th. Argus raised Clorox to a “hold” rating in a research report on Tuesday, June 4th. Morgan Stanley reiterated an “equal weight” rating and issued a $160.00 price target on shares of Clorox in a research report on Tuesday, March 26th. Barclays cut their price objective on Clorox from $136.00 to $132.00 and set an “underweight” rating on the stock in a report on Thursday, May 2nd. Finally, Deutsche Bank Aktiengesellschaft decreased their target price on shares of Clorox from $155.00 to $151.00 and set a “hold” rating for the company in a report on Wednesday, April 17th. Five research analysts have rated the stock with a sell rating and fourteen have assigned a hold rating to the stock. Based on data from MarketBeat, the stock currently has a consensus rating of “Hold” and a consensus target price of $145.33.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.